PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 27, 2012European Heart Journal282 citationsOpen Access

Increased mortality among patients taking digoxin--analysis from the AFFIRM study

View Full Paper
MWMatthew G. WhitbeckRCRichard CharnigoPKPaul Khairy

Structured PICO

Does digoxin increase all-cause mortality in patients with atrial fibrillation?

P
Population
Patients with atrial fibrillation (AF), regardless of gender or the presence or absence of heart failure (HF) (from the AFFIRM study)
I
Intervention
Digoxin
O
Outcome
All-cause mortalityhard clinical

Digoxin use in patients with atrial fibrillation is associated with increased all-cause mortality, calling its widespread use into question.

Abstract

Digoxin was associated with a significant increase in all-cause mortality in patients with AF after correcting for clinical characteristics and comorbidities, regardless of gender or of the presence or absence of HF. These findings call into question the widespread use of digoxin in patients with AF.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Whitbeck et al. (2012) studied this question.

synapsesocial.com/papers/69d72dc1d2e0540b79f507bbhttps://doi.org/10.1093/eurheartj/ehs348
Ask AI
Helpful
Bookmark
Share
View Full Paper